CA2414508A1 - Dispositif d'impression pour moniteurs medicaux personnels - Google Patents

Info

Publication number

CA2414508A1

CA2414508A1 CA 2414508 CA2414508A CA2414508A1 CA 2414508 A1 CA2414508 A1 CA 2414508A1 CA 2414508 CA2414508 CA 2414508 CA 2414508 A CA2414508 A CA 2414508A CA 2414508 A1 CA2414508 A1 CA 2414508A1

Authority

CA

Canada

Prior art keywords

data

printing device

body fluid

fluid chemistry

chemistry analyzer

Prior art date

2001-12-17

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 238000007639 printing Methods 0.000 title claims abstract description 33
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 25
• 239000008103 glucose Substances 0.000 claims abstract description 25
• 239000008280 blood Substances 0.000 claims abstract description 24
• 210000004369 blood Anatomy 0.000 claims abstract description 24
• 238000004891 communication Methods 0.000 claims description 19
• 210000001124 body fluid Anatomy 0.000 claims description 15
• 239000010839 body fluid Substances 0.000 claims description 14
• 238000000034 method Methods 0.000 claims description 3
• 238000012544 monitoring process Methods 0.000 claims 1
• 238000002560 therapeutic procedure Methods 0.000 abstract description 21
• 238000004458 analytical method Methods 0.000 abstract description 4
• 230000008901 benefit Effects 0.000 abstract description 3
• 238000007405 data analysis Methods 0.000 abstract description 2
• 238000013479 data entry Methods 0.000 abstract description 2
• 238000012806 monitoring device Methods 0.000 abstract 2
• 238000012546 transfer Methods 0.000 description 11
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
• 102000004877 Insulin Human genes 0.000 description 5
• 229940125396 insulin Drugs 0.000 description 5
• 108090001061 Insulin Proteins 0.000 description 4
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
• 238000005516 engineering process Methods 0.000 description 3
• 238000010586 diagram Methods 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 238000013500 data storage Methods 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 230000003203 everyday effect Effects 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 238000007726 management method Methods 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 238000012549 training Methods 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1